Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

Related Citations for PubMed (Select 20143398)

1.

Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis.

Clere N, Corre I, Faure S, Guihot AL, Vessières E, Chalopin M, Morel A, Coqueret O, Hein L, Delneste Y, Paris F, Henrion D.

Int J Cancer. 2010 Nov 15;127(10):2279-91. doi: 10.1002/ijc.25234.

PMID:
20143398
2.

Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling.

Anandanadesan R, Gong Q, Chipitsyna G, Witkiewicz A, Yeo CJ, Arafat HA.

J Gastrointest Surg. 2008 Jan;12(1):57-66. Epub 2007 Nov 17.

PMID:
18026817
3.

[Antitumor effect of recombinant T7 phage vaccine expressing xenogenic vascular endothelial growth factor on Lewis lung cancer in mice].

Li XH, Tang L, Liu D, Sun HM, Zhou CC, Tan LS, Wang LP, Zhang PD, Zhang SQ.

Ai Zheng. 2006 Oct;25(10):1221-6. Chinese.

PMID:
17059764
4.

Roles for host and tumor angiotensin II type 1 receptor in tumor growth and tumor-associated angiogenesis.

Imai N, Hashimoto T, Kihara M, Yoshida S, Kawana I, Yazawa T, Kitamura H, Umemura S.

Lab Invest. 2007 Feb;87(2):189-98. Epub 2006 Dec 18.

5.

S1P(2), the G protein-coupled receptor for sphingosine-1-phosphate, negatively regulates tumor angiogenesis and tumor growth in vivo in mice.

Du W, Takuwa N, Yoshioka K, Okamoto Y, Gonda K, Sugihara K, Fukamizu A, Asano M, Takuwa Y.

Cancer Res. 2010 Jan 15;70(2):772-81. doi: 10.1158/0008-5472.CAN-09-2722. Epub 2010 Jan 12.

6.

Vascular endothelial growth factor-induced tumor angiogenesis and tumorigenicity in relation to metastasis in a HT1080 human fibrosarcoma cell model.

Mori A, Arii S, Furutani M, Hanaki K, Takeda Y, Moriga T, Kondo Y, Gorrin Rivas MJ, Imamura M.

Int J Cancer. 1999 Mar 1;80(5):738-43.

PMID:
10048976
7.

Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis.

Cao Z, Kelly DJ, Cox A, Casley D, Forbes JM, Martinello P, Dean R, Gilbert RE, Cooper ME.

Kidney Int. 2000 Dec;58(6):2437-51.

8.

Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin.

Shiau AL, Teo ML, Chen SY, Wang CR, Hsieh JL, Chang MY, Chang CJ, Chao J, Chao L, Wu CL, Lee CH.

BMC Cancer. 2010 May 31;10:245. doi: 10.1186/1471-2407-10-245.

9.

Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis.

Li P, Kondo T, Numaguchi Y, Kobayashi K, Aoki M, Inoue N, Okumura K, Murohara T.

Hypertension. 2008 Feb;51(2):252-8. Epub 2007 Dec 17.

10.

Expression of the local angiotensin II system in gastric cancer may facilitate lymphatic invasion and nodal spread.

Carl-McGrath S, Ebert MP, Lendeckel U, Röcken C.

Cancer Biol Ther. 2007 Aug;6(8):1218-26. Epub 2007 Aug 10.

11.

Statins have biphasic effects on angiogenesis.

Weis M, Heeschen C, Glassford AJ, Cooke JP.

Circulation. 2002 Feb 12;105(6):739-45.

12.

Bee venom inhibits tumor angiogenesis and metastasis by inhibiting tyrosine phosphorylation of VEGFR-2 in LLC-tumor-bearing mice.

Huh JE, Baek YH, Lee MH, Choi DY, Park DS, Lee JD.

Cancer Lett. 2010 Jun 1;292(1):98-110. doi: 10.1016/j.canlet.2009.11.013. Epub 2010 Feb 25.

PMID:
20188461
13.

Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.

Komuro A, Yashiro M, Iwata C, Morishita Y, Johansson E, Matsumoto Y, Watanabe A, Aburatani H, Miyoshi H, Kiyono K, Shirai YT, Suzuki HI, Hirakawa K, Kano MR, Miyazono K.

J Natl Cancer Inst. 2009 Apr 15;101(8):592-604. doi: 10.1093/jnci/djp058. Epub 2009 Apr 7.

14.

Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis.

Fujita M, Hayashi I, Yamashina S, Itoman M, Majima M.

Biochem Biophys Res Commun. 2002 Jun 7;294(2):441-7.

PMID:
12051731
15.

Deguelin--an inhibitor to tumor lymphangiogenesis and lymphatic metastasis by downregulation of vascular endothelial cell growth factor-D in lung tumor model.

Hu J, Ye H, Fu A, Chen X, Wang Y, Chen X, Ye X, Xiao W, Duan X, Wei Y, Chen L.

Int J Cancer. 2010 Nov 15;127(10):2455-66. doi: 10.1002/ijc.25253.

PMID:
20162567
16.

Angiotensin II AT2 receptor regulates ureteric bud morphogenesis.

Song R, Spera M, Garrett C, El-Dahr SS, Yosypiv IV.

Am J Physiol Renal Physiol. 2010 Mar;298(3):F807-17. doi: 10.1152/ajprenal.00147.2009. Epub 2009 Dec 23.

17.

Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.

Nör JE, Christensen J, Liu J, Peters M, Mooney DJ, Strieter RM, Polverini PJ.

Cancer Res. 2001 Mar 1;61(5):2183-8.

19.

Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.

Huh JI, Calvo A, Stafford J, Cheung M, Kumar R, Philp D, Kleinman HK, Green JE.

Oncogene. 2005 Jan 27;24(5):790-800. Erratum in: Oncogene. 2005 Jun 9;24(25):4164.

PMID:
15592523
20.

Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.

Nagai N, Izumi-Nagai K, Oike Y, Koto T, Satofuka S, Ozawa Y, Yamashiro K, Inoue M, Tsubota K, Umezawa K, Ishida S.

Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4342-50.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk